Literature DB >> 15084848

Expression of a transcription factor, SOX9, in Sertoli-stromal cell tumors of the ovary.

Noriko Kato1, Masayuki Fukase, Teiichi Motoyama.   

Abstract

Two cases of ovarian Sertoli-stromal cell tumor were examined for expression of a transcription factor, SOX9, which plays an essential role in Sertoli cell differentiation, downstream of Sry, as in the testis. By reverse transcriptase polymerase chain reaction, SOX9 mRNA was expressed in both tumors, despite the absence of Sry. These findings suggest that SOX9 expression probably plays some role in Sry-independent testicular differentiation in ovarian Sertoli-stromal cell tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084848     DOI: 10.1097/00004347-200404000-00014

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  4 in total

1.  Molecular-cytogenetic characterisation of sex cord-stromal tumours: CGH analysis in sertoli cell tumours of the testis.

Authors:  I Verdorfer; A Höllrigl; U Strasser; M Susani; A Hartmann; H Rogatsch; G Mikuz
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

2.  The versatile functions of Sox9 in development, stem cells, and human diseases.

Authors:  Alice Jo; Sahitya Denduluri; Bosi Zhang; Zhongliang Wang; Liangjun Yin; Zhengjian Yan; Richard Kang; Lewis L Shi; James Mok; Michael J Lee; Rex C Haydon
Journal:  Genes Dis       Date:  2014-12

3.  SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage.

Authors:  Xuehui Hong; Wenyu Liu; Ruipeng Song; Jamie J Shah; Xing Feng; Chi Kwan Tsang; Katherine M Morgan; Samuel F Bunting; Hiroyuki Inuzuka; X F Steven Zheng; Zhiyuan Shen; Hatem E Sabaawy; LianXin Liu; Sharon R Pine
Journal:  Nucleic Acids Res       Date:  2016-08-26       Impact factor: 16.971

4.  Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis.

Authors:  Haihua Ruan; Shuangyan Hu; Hongyu Zhang; Gang Du; Xiaoting Li; Xiaobo Li; Xichuan Li
Journal:  Oncotarget       Date:  2017-11-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.